{"id":"https://genegraph.clinicalgenome.org/r/eafffcd2-dded-4c0a-82e1-84043a5dda1fv1.0","type":"EvidenceStrengthAssertion","dc:description":"CFI was first reported in relation to autosomal dominant C3 glomerulopathy (C3G) in 2012 (Servais et al., PMID: 22456601). C3G is characterized by complement dysregulation occurring in the fluid phase and in the glomerular microenvironment (Smith et al., 2019, PMID: 30692664). The term C3G is inclusive of dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in phenotypic variability. Therefore, the following disease entities have been split into multiple disease entities, atypical hemolytic uremic syndrome (aHUS) (OMIM:612923) and C3G. The split curation for autosomal dominant aHUS has been curated separately. Seven variants (missense, nonsense, and frameshift) that have been reported in 7 probands in 3 publications (PMIDs: 22456601, 35619721, 37615951) are included in this curation. The mechanism of pathogenicity is known to be loss of function, causing dysregulation of the complement-mediated immune pathway. This gene-disease relationship is also supported by biochemical function in the complement-mediated immune pathway, protein interaction with factor H, functional alteration demonstrated by reduced *in vitro* expression in HEK293T cells and low FI plasma levels caused by variants observed in patients, and a mouse model recapitulating C3G as seen in human patients (PMIDs: 28671664, 32510551, 34149444). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Complement-Mediated Kidney Diseases GCEP on the meeting date April 17, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/eafffcd2-dded-4c0a-82e1-84043a5dda1f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/943f6c06-e32b-4052-8628-4c28de20c838","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/943f6c06-e32b-4052-8628-4c28de20c838_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10069","date":"2024-06-28T18:44:25.824Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/943f6c06-e32b-4052-8628-4c28de20c838_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10069","date":"2024-06-28T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/943f6c06-e32b-4052-8628-4c28de20c838_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c90efe7-7731-467f-aeb4-1acc3a5a91b9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c90efe7-7731-467f-aeb4-1acc3a5a91b9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22456601","allele":{"id":"https://genegraph.clinicalgenome.org/r/055a0920-84f1-43a0-b616-2b643acd9103","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000204.5(CFI):c.917T>G (p.Ile306Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357859538"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/19b66905-ddd0-456a-81e1-796b58ba0561","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19b66905-ddd0-456a-81e1-796b58ba0561_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35619721","allele":{"id":"https://genegraph.clinicalgenome.org/r/b6e760fb-7084-4bf1-9b8b-130252a186e7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000204.5(CFI):c.407A>C (p.Lys136Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357863983"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d2d77c8e-ee14-4951-b690-7cec10dded75","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2d77c8e-ee14-4951-b690-7cec10dded75_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Significantly impaired FI function (C3b cleavage) with all cofactors (FH, MCP, sCR1).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d2d77c8e-ee14-4951-b690-7cec10dded75_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35619721","allele":{"id":"https://genegraph.clinicalgenome.org/r/2ec2a137-abd0-4637-ba13-eb2b5e1fa54d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000204.5(CFI):c.1006C>G (p.Arg336Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3042053"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/75de442a-c60d-49c6-a677-9678b4ce0c72","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/75de442a-c60d-49c6-a677-9678b4ce0c72_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37615951","allele":{"id":"https://genegraph.clinicalgenome.org/r/386afee3-0135-492f-84e7-5424f7235104","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000204.5(CFI):c.1750T>C (p.Ter584Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3041827"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a3ad13ce-4925-4308-80c0-8e556303a95a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3ad13ce-4925-4308-80c0-8e556303a95a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35619721","allele":{"id":"https://genegraph.clinicalgenome.org/r/dfccc987-957d-40e3-bd46-b78585448829","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000204.5(CFI):c.1111G>A (p.Gly371Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA103690810"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fa5a2c25-413e-40b2-86b1-f340e4376bca","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa5a2c25-413e-40b2-86b1-f340e4376bca_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35619721","allele":{"id":"https://genegraph.clinicalgenome.org/r/130fcfe5-60c5-4200-8fb1-759590fbd110","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000204.5(CFI):c.1467del (p.Lys490AsnfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2830929994"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/800f8ef6-bce2-4075-ad11-1e2d7de63cdc","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/800f8ef6-bce2-4075-ad11-1e2d7de63cdc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37615951","allele":{"id":"https://genegraph.clinicalgenome.org/r/e75e4b1f-98cd-45cc-a036-80366274073f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000204.5(CFI):c.1420C>T (p.Arg474del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256211"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3.9},{"id":"https://genegraph.clinicalgenome.org/r/943f6c06-e32b-4052-8628-4c28de20c838_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/943f6c06-e32b-4052-8628-4c28de20c838_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/631d3f15-88a8-4d11-939c-bffd3344d26b","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a7b58bc-386e-4df7-a86e-871ece3cb497","type":"Finding","dc:description":"The mice were all normal in either SPF (specific pathogen free) or regular environment. When treated with lipopolysaccharides (LPS), a bacterial endotoxin that mimics infection and sepsis, the mice developed albuminuria, kidney function impairment, and C3 glomerular deposition at levels comparable with the wild-type mice.\n\nThe mice with other genotypes concerning CFI D288G and P467S were also tested in parallel. Unexpectedly, the D288G homozygotes all developed severe mesangial deposition of C3 in the LPS model, indicating that CFI D288G variation was involved in the C3 deposition, a key feature of C3GN.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34149444","rdfs:label":"Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/943f6c06-e32b-4052-8628-4c28de20c838_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e0d9813-341f-4b06-a588-69ff8d4049c0","type":"EvidenceLine","dc:description":"Upgraded for consistent effect for variants identified in patients with disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e33348fa-8129-4ef8-8ff5-a94e7ad5497a","type":"FunctionalAlteration","dc:description":"Multiple variants demonstrated significantly reduced expression compared to WT in vitro often paired with low FI plasma level in HEK293T cells:","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32510551","rdfs:label":"Significantly reduced expression compared to WT in vitro"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/943f6c06-e32b-4052-8628-4c28de20c838_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/776643f6-4090-4469-bf66-678ea5a4e476","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ccb5861a-f679-4177-92a9-f8ba01663733","type":"Finding","dc:description":"These complexes are unable to drive opsonization as they are unable to form C3 or C5 convertases due to pathogenic variation in CFI, leading to dysregulation of the AP and ultimately C3G.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28671664","rdfs:label":"Dysregulation of the AP","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5a608c91-7ce0-40e8-8ba6-890424d6338b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/095d69cc-38e5-4a2f-8608-989e0553cc38","type":"Finding","dc:description":"FH assists in binding FI to the C3b–FH complex and the complex activates FI to cleave C3b at its first cleavage site. FI binds C3b–FH primarily at the CTC domain of C3b and domains CCP2–3 of FH. Interactions between C3b–FH and FI contribute, either directly or indirectly, to stabilization of the catalytic SP domain of FI and hence induce proteolytic activity to the enzyme.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28671664","rdfs:label":"Interaction with CFH","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4}],"evidenceStrength":"Moderate","sequence":8545,"specifiedBy":"GeneValidityCriteria10","strengthScore":7.9,"subject":{"id":"https://genegraph.clinicalgenome.org/r/qGELsWZtWCY","type":"GeneValidityProposition","disease":"obo:MONDO_0013892","gene":"hgnc:5394","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_943f6c06-e32b-4052-8628-4c28de20c838-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}